XBiotech (XBIT) Common Equity (2014 - 2026)
XBiotech's Common Equity was $128.46 million in Q2 2026, down 25.8% from $173.06 million a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at XBiotech came in at $140.35 million, down 23.0% from FY2024.
- Common Equity has now declined for six consecutive years, with a five-year compound annual growth rate of -16.6% (FY2020 to FY2025).
- In earlier years, Common Equity was $182.27 million in FY2024 (-16.7%), $218.85 million in FY2023 (-9.0%), $240.4 million in FY2022 (-10.8%) and $269.39 million in FY2021 (-22.7%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q3 2019.
- Over the past five years, the year-over-year decline in Common Equity ranged from 9.0% (Q4 2023) to 26.6% (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | XBiotech | 65.55 Mn | 65.55 Mn | - | 128.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 128.46 Mn |
| Dec 31, 2025 | 140.35 Mn |
| Sep 30, 2025 | 167.08 Mn |
| Jun 30, 2025 | 173.06 Mn |
| Mar 31, 2025 | 174.71 Mn |
| Dec 31, 2024 | 182.27 Mn |
| Sep 30, 2024 | 192.12 Mn |
| Jun 30, 2024 | 196.70 Mn |
| Mar 31, 2024 | 209.28 Mn |
| Dec 31, 2023 | 218.85 Mn |
| Sep 30, 2023 | 222.66 Mn |
| Jun 30, 2023 | 229.06 Mn |
| Mar 31, 2023 | 236.91 Mn |
| Dec 31, 2022 | 240.40 Mn |
| Sep 30, 2022 | 244.81 Mn |
| Jun 30, 2022 | 255.80 Mn |
| Mar 31, 2022 | 265.56 Mn |
| Dec 31, 2021 | 269.39 Mn |
| Sep 30, 2021 | 274.16 Mn |
| Jun 30, 2021 | 348.56 Mn |
API Access
XBiotech Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();